Eli Lilly & Co. | Zyprexa Settlement | Eli Lilly Settles West Virginia Lawsuit

Eli Lilly ’s West Virginia $22.5 million Zyprexa Lawsuit Settlement
On August 20, 2009, Bloomberg news announced that Eli Lilly & Co. has agreed to pay $22.5 million to settle a Zyprexa lawsuit brought by the state of West Virginia claiming the company improperly marketed its antipsychotic drug Zyprexa. Zyprexa has been the subject of [...]

Lawsuits Filed in Texas Against Matrixx Initiatives Over Zicam Cold Remedy

Several additional Zicam lawsuits have been filed in Texas by comsumers who claim the recalled nasal version of the Zicam cold remedies caused them to lose their sense of smell due to zinc exposure.  The latest Zicam lawsuits were filed in the Marshall Division of the Eastern District of Texas.
One of the Zicam lawsuits, filed [...]

Denture Cream Lawsuits | PoliGrip Lawsuits Against GlaxoSmithKline PLC & Fixodent Lawsuits Against Proctor & Gamble Consolidated In An MDL Proceeding

On June 9, 2009, the Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order centralizing In re: Denture Cream Product Liability Litigation, MDL-2051, in the Southern District of Florida before United States District Court Judge Cecilia M. Altonaga.   The Fixodent lawsuits were brought against  Proctor & Gamble, while the PoliGrip lawsuits were brought against GlaxoSmithKline PLC.   The plaintiffs [...]

FDA Warning | Matrixx Initiatives | Zicam Cold Remedy Gels and Swabs

FDA Warning Letter Alert:  Matrixx Initiatives Issued FDA Warning Letter Regarding  Zicam Cold Remedy Gels and Swabs | Intranasal Zinc Product Linked to Loss of Sense of Smell
On June 16, 2009, the FDA issued a press release and warning letter advising consumers to stop using three products marketed over-the-counter by Matrixx Initiatives as cold remedies because they are associated with [...]

Recall | Barr Laboratories, Inc. Recalls Dextroamphetamine & Amphetamine (20mg Tablets, Lot number 311756)

Recall Alert:  Dextroamphetamine & Amphetamine Recalled By Barr Laboratories, Inc.
On August 13, 2009, the FDA issued a press release and notice of recall on its website anouncing that Barr Laboratories, Inc. was initiating a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20mg Tablets, 100 count [...]

test